Characterization of α-synuclein aggregation and synergistic toxicity with protein tau in yeast

被引:82
作者
Zabrocki, P
Pellens, K
Vanhelmont, T
Vandebroek, T
Griffioen, G
Wera, S
Van Leuven, F
Winderickx, J
机构
[1] Katholieke Univ Leuven, LEGT EGG, Louvain, Belgium
[2] NV reMYND, Louvain, Belgium
关键词
Alzheimer's disease; Parkinson's disease; Tau; yeast; alpha-synuclein;
D O I
10.1111/j.1742-4658.2005.04571.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A yeast model was generated to study the mechanisms and phenotypical repercussions of expression of alpha-synuclein as well as the coexpression of protein tau. The data show that aggregation of alpha-synuclein is a nucleation-elongation process initiated at the plasma membrane. Aggregation is consistently enhanced by dimethyl sulfoxide, which is known to increase the level of phospholipids and membranes in yeast cells. Aggregation of alpha-synuclein was also triggered by treatment of the yeast cells with ferrous ions, which are known to increase oxidative stress. In addition, data are presented in support of the hypothesis that degradation of alpha-synuclein occurs via autophagy and proteasomes and that aggregation of alpha-synuclein disturbs endocytosis. Reminiscent of observations in double-transgenic mice, coexpression of alpha-synuclein and protein tau in yeast cells is synergistically toxic, as exemplified by inhibition of proliferation. Taken together, the data show that these yeast models recapitulate major aspects of alpha-synuclein aggregation and cytotoxicity, and offer great potential for defining the underlying mechanisms of toxicity and synergistic actions of alpha-synuclein and protein tau.
引用
收藏
页码:1386 / 1400
页数:15
相关论文
共 68 条
  • [31] Alzheimer's and Parkinson's disease -: overlapping or synergistic pathologies?
    Kurosinski, P
    Guggisberg, M
    Götz, J
    [J]. TRENDS IN MOLECULAR MEDICINE, 2002, 8 (01) : 3 - 5
  • [32] Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human α-synuclein
    Lakso, M
    Vartiainen, S
    Moilanen, AM
    Sirviö, J
    Thomas, JH
    Nass, R
    Blakely, RD
    Wong, G
    [J]. JOURNAL OF NEUROCHEMISTRY, 2003, 86 (01) : 165 - 172
  • [33] Membrane-bound α-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form
    Lee, HJ
    Choi, C
    Lee, SJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (01) : 671 - 678
  • [34] Characterization of cytoplasmic α-synuclein aggregates -: Fibril formation is tightly linked to the inclusion-forming process in cells
    Lee, HJ
    Lee, SJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (50) : 48976 - 48983
  • [35] More than just two peas in a pod:: common amyloidogenic properties of tau and α-synuclein in neurodegenerative diseases
    Lee, VMY
    Giasson, BI
    Trojanowski, JQ
    [J]. TRENDS IN NEUROSCIENCES, 2004, 27 (03) : 129 - 134
  • [36] Neurodegenerative tauopathies
    Lee, VMY
    Goedert, M
    Trojanowski, JQ
    [J]. ANNUAL REVIEW OF NEUROSCIENCE, 2001, 24 : 1121 - 1159
  • [37] Proteasomal inhibition by α-synuclein filaments and oligomers
    Lindersson, E
    Beedholm, R
    Hojrup, P
    Moos, T
    Gai, WP
    Hendil, KB
    Jensen, PH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) : 12924 - 12934
  • [38] Tau in Alzheimer's disease
    Mandelkow, EM
    Mandelkow, E
    [J]. TRENDS IN CELL BIOLOGY, 1998, 8 (11) : 425 - 427
  • [39] Histochemical features of stress-induced aggregates in α-synuclein overexpressing cells
    Matsuzaki, M
    Hasegawa, T
    Takeda, A
    Kikuchi, A
    Furukawa, K
    Kato, Y
    Itoyama, Y
    [J]. BRAIN RESEARCH, 2004, 1004 (1-2) : 83 - 90
  • [40] Proteasome inhibition causes nigral degeneration with inclusion bodies in rats
    McNaught, KS
    Björklund, LM
    Belizaire, R
    Isacson, O
    Jenner, P
    Olanow, CW
    [J]. NEUROREPORT, 2002, 13 (11) : 1437 - 1441